top of page


Causal AI: The Key to Tackling Complexity in Pharma
by Paul Arora Greg Myers ’ recent opinion piece  highlights the promise of artificial intelligence in reshaping drug development and...
Jan 132 min read


Inka Health Partners with GIPAM GmbH to Elevate HEOR and Regulatory Science
By: Paul Arora We are thrilled to announce a strategic partnership between Inka Health and GIPAM GmbH , marking a significant milestone...
Sep 17, 20242 min read


Using Synthetic Real-World Data for External Control Arm Analysis in Oncology – The ECLIPSE Study
By: Alind Gupta In the evolving landscape of clinical research, single-arm trials have become essential tools, particularly when...
Sep 12, 20243 min read
bottom of page